Peptide Therapeutics Foundation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2008 | 169,980 | 132,531 | 37,449 | 3.4 | — |
| 2009 | 143,031 | 145,751 | −2,720 | 2.9 | — |
| 2010 | 147,763 | 102,330 | 45,433 | 9.4 | — |
| 2011 | 197,060 | 108,526 | 88,534 | 18.7 | — |
| 2012 | 167,789 | 109,530 | 58,259 | 27.8 | — |
| 2013 | 122,329 | 101,707 | 20,622 | 32.4 | — |
| 2014 | 137,675 | 113,018 | 24,657 | 31.7 | — |
| 2015 | 142,758 | 110,455 | 32,303 | 36.0 | — |
| 2016 | 136,200 | 121,626 | 14,574 | 34.1 | — |
| 2017 | 172,574 | 107,539 | 65,035 | 45.8 | — |
| 2018 | 127,978 | 106,620 | 21,358 | 48.6 | — |
| 2019 | 121,265 | 110,889 | 10,376 | 47.9 | — |
| 2020 | 43,680 | 46,276 | −2,596 | 114.1 | — |
| 2021 | 66,103 | 115,909 | −49,806 | 38.7 | — |
| 2022 | 110,022 | 129,463 | −19,441 | 26.1 | — |
| 2023 | 134,883 | 157,903 | −23,020 | 21.8 | — |
In its most recent public year (2023), this organization spent $23,020 more than it brought in. Its reserves stood at about 21.8 months of spending, up from 3.4 in 2008.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Peptide Therapeutics Foundation's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works